General Information of Drug (ID: DM0RAPC)

Drug Name
US10030004, Compound 19 Drug Info
Synonyms SCHEMBL16879133; BDBM280352; US10030004, Compound 19; Synthesis of N-(2-aminoethyl)-4-[[2-(5-chloro-2-fluoro-phenyl)-5-isopropyl-4-pyridyl]amino]pyridine-3-carboxamide
Cross-matching ID
PubChem CID
118211014
TTD Drug ID
DM0RAPC

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Patented Agent(s)
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
US9682983, 1 DM6EQVT N. A. N. A. Patented [2]
BDBM108945 DMZD6IJ N. A. N. A. Patented [2]
US9682983, 33 DM6R1YP N. A. N. A. Patented [2]
US10030004, Compound 33 DMD0GN6 N. A. N. A. Patented [1]
US10030004, Compound 11a DMG4T13 N. A. N. A. Patented [1]
PMID23639540C13d DMSTQGH Discovery agent N.A. Investigative [3]
PMID23639540C13r DMHBZ0N Discovery agent N.A. Investigative [3]
⏷ Show the Full List of 7 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Activin receptor type IB (ACVR1B) TTPKHTZ ACV1B_HUMAN Inhibitor [1]

References

1 Compounds and methods of use. US10030004.
2 BMP inhibitors and methods of use thereof. US9682983.
3 Synthesis and structure-activity relationships of a novel and selective bone morphogenetic protein receptor (BMP) inhibitor derived from the pyrazolo[1.5-a]pyrimidine scaffold of dorsomorphin: the discovery of ML347 as an ALK2 versus ALK3 selective MLPCN probe. Bioorg Med Chem Lett. 2013 Jun 1;23(11):3248-52.